Myomo (NYSEAMERICAN:MYO) Insider Sells $20,464.00 in Stock

Myomo, Inc. (NYSEAMERICAN:MYO) insider Harry Kovelman sold 20,464 shares of the firm’s stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $1.00, for a total value of $20,464.00. Following the sale, the insider owned 120,154 shares in the company, valued at $120,154. The trade was a 14.55% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Harry Kovelman also recently made the following trade(s):

• On Thursday, May 28th, Harry Kovelman sold 11,536 shares of Myomo stock. The shares were sold at an average price of $1.02, for a total value of $11,766.72.

Myomo Stock Performance

NYSEAMERICAN MYO opened at $1.09 on Monday. The stock’s 50-day simple moving average is $0.81 and its two-hundred day simple moving average is $0.85. Myomo, Inc. has a twelve month low of $0.61 and a twelve month high of $3.14. The company has a quick ratio of 2.36, a current ratio of 2.73 and a debt-to-equity ratio of 1.21. The company has a market capitalization of $42.12 million, a price-to-earnings ratio of -3.03 and a beta of 1.47.

Wall Street Analysts Forecast Growth

Separately, Craig Hallum restated a “buy” rating on shares of Myomo in a research report on Tuesday, March 10th. Four research analysts have rated the stock with a Buy rating, According to MarketBeat.com, Myomo currently has a consensus rating of “Buy” and an average target price of $7.67.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of MYO. Rosalind Advisors Inc. increased its holdings in shares of Myomo by 33.0% in the second quarter. Rosalind Advisors Inc. now owns 3,595,788 shares of the company’s stock worth $7,767,000 after buying an additional 892,127 shares during the period. Jefferies Financial Group Inc. purchased a new position in shares of Myomo in the fourth quarter worth about $641,000. Geode Capital Management LLC increased its holdings in shares of Myomo by 160.8% in the second quarter. Geode Capital Management LLC now owns 669,281 shares of the company’s stock worth $1,446,000 after buying an additional 412,631 shares during the period. Centiva Capital LP purchased a new position in shares of Myomo in the third quarter worth about $190,000. Finally, Prescott Group Capital Management L.L.C. purchased a new position in shares of Myomo in the fourth quarter worth about $169,000. Hedge funds and other institutional investors own 44.99% of the company’s stock.

Myomo Company Profile

Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company’s flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users’ own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.

Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.